DIA

Dia has invented an electrochemical sensor that can measure a wide variety of chemical biomarkers non-invasively in saliva or sweat. The data is sent via Bluetooth to an app on the user’s smartphone and analyzed in real-time. From the app, it can be securely sent to a third party. To date, we have measured hormones, electrolytes, neurotransmitters and metabolites. At DIA, we let the biology dictate which analyte we put on which platform – our wearable arm sleeve for sweat or our table-top device for saliva – because some biomarkers, such as cortisol fluctuate throughout the day and need to be monitored through a wearable sensor, while others, such as creatinine are more suitable to a daily saliva test.

DIA headquartered in United States, North America, operates in the Health Care, Fitness, Wellness, Medical Device sector. The company focuses on Health Care and has secured $46.1M in funding across 96 round(s). With a team of 1-10 employees, DIA is actively contributing to advancements in Health Care. Their latest funding round, Grant - DIA, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.